Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation
The de-extinction startup is looking to double or triple its previous valuation, according to the report.
2026-07-21
原文 →
找到 2 篇相关文章
The de-extinction startup is looking to double or triple its previous valuation, according to the report.
Colossal Biosciences will be biobanking tissues from all of them as well.